Clinical Trial Update: Digital Pathology and AI for Liver Outcomes in MASLD

View source ↗

Summary

A completed clinical trial sponsored by PharmaNest evaluated digital pathology and AI for liver outcomes in MASLD. The study explored how digital pathology and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: PharmaNest, Inc | Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease | Status: COMPLETED